<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04608227</url>
  </required_header>
  <id_info>
    <org_study_id>Darnord-2020</org_study_id>
    <nct_id>NCT04608227</nct_id>
  </id_info>
  <brief_title>Non-invasive Haemodynamic Monitoring to Predict Spinal Hypotension During Caesarian Section</brief_title>
  <official_title>Can Non-invasive Haemodynamic Monitoring With Clearsight(r) Predict Spinal Hypotension During Caesarian Section? A Prospective Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Nord</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Nord</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Spinal anaesthesia for elective caesarean section is associated with maternal hypotension,&#xD;
      secondary to alteration of sympathetic tone and hypovolemia, in up to 70% of cases.&#xD;
&#xD;
      Our objective, in this prospective single-centre observational study, was to assess the&#xD;
      ability of change in systolic ejection volume after 45Â° passive leg raising to predict&#xD;
      hypotension after spinal anaesthesia. Systolic ejection volum was monitored with non-invasive&#xD;
      Clearsight Device just before elective caesarean section in third trimester pregnant women.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2020</start_date>
  <completion_date type="Anticipated">February 15, 2021</completion_date>
  <primary_completion_date type="Actual">November 26, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Systolic Ejection volume (mL)</measure>
    <time_frame>30 minutes</time_frame>
    <description>Systolic ejection volume is measured using Clearsight (non invasive monitoring device)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Velocity - Time - Integral (cm)</measure>
    <time_frame>30 minutes</time_frame>
    <description>Velocity - Time - Integral is measured using transthoracic cardiac ultrasound</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Hypotension</condition>
  <condition>Pregnancy Related</condition>
  <condition>Spinal Anesthetics Causing Adverse Effects in Therapeutic Use</condition>
  <arm_group>
    <arm_group_label>Third trimester pregnant women undergoing ceasarean section</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Clearsight monitoring</intervention_name>
    <description>Non invasive hemodynamic monitoring using a finger cuff Cardiac ultrasound performed to calculate Velocity - Time - integral (VTI) Both intervention are performed before and after a passive leg raising challenge.</description>
    <arm_group_label>Third trimester pregnant women undergoing ceasarean section</arm_group_label>
    <other_name>Cardiac ultrasound</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        prospective inclusion of 3 rd trimester pregnant women undergoing spinal anesthesia for&#xD;
        elective ceasarean section&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  third trimester pregnant women undergoing elective ceasarean section under spinal&#xD;
             anesthesia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  emergent ceasarean section&#xD;
&#xD;
          -  eclampsia or pre-eclampsia&#xD;
&#xD;
          -  undergoing anti-hypertensive treatment&#xD;
&#xD;
          -  arythmia&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Only pregmant women</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Gary DUCLOS, MD</last_name>
    <phone>+33491965531</phone>
    <email>gary.duclos@ap-hm.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marc Leone, PhD, MD</last_name>
    <phone>+4491965330</phone>
    <email>marc.leone@ap-hm.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Departement anesthesie reanimation hopital nord</name>
      <address>
        <city>Marseille</city>
        <zip>13015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Leone, MD</last_name>
      <email>mleone@ap-hm.fr</email>
    </contact>
    <contact_backup>
      <last_name>laurent Zieleskiewicz, MD</last_name>
      <email>lZieleskiewicz@ap-hm.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>October 19, 2020</study_first_submitted>
  <study_first_submitted_qc>October 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 29, 2020</study_first_posted>
  <last_update_submitted>November 26, 2020</last_update_submitted>
  <last_update_submitted_qc>November 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Nord</investigator_affiliation>
    <investigator_full_name>Gary DUCLOS</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypotension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

